Serum levels of Growth Arrest-Specific 6 protein and soluble AXL in patients with ST-segment elevation myocardial infarction
Guillem Caldentey(Hospital Clínic de Barcelona), Jose T. Ortiz‐Pérez(Hospital Quirón Teknon), Rosario J. Perea(Hospital Clínic de Barcelona), Antonio Berruezo(Hospital Quirón Teknon), Teresa M. de Caralt(European Molecular Biology Laboratory), Pablo Garcı́a de Frutos(Institut d'Investigacions Biomèdiques de Barcelona), Helena Cristóbal(Institut d'Investigacions Biomèdiques de Barcelona), Manel Garabito(Institut d'Investigacions Biomèdiques de Barcelona), Xavier Bosch(Universitat de Barcelona), Rodolfo San Antonio(Hospital Quirón Teknon), Jany Rodríguez(Hospital Clínic de Barcelona), Eduardo Flores‐Umanzor(Hospital Clínic de Barcelona)
Cited by 27
Related Papers
Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies
|Journal of the American College of Cardiology|2013|631
Pulmonary Sarcoidosis: Typical and Atypical Manifestations at High-Resolution CT with Pathologic Correlation
|Radiographics|2010|490
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
|EP Europace|2019|461
Gender Differences in Clinical Manifestations of Brugada Syndrome
|Journal of the American College of Cardiology|2008|280
Three-Dimensional Architecture of Scar and Conducting Channels Based on High Resolution ce-CMR
|Circulation Arrhythmia and Electrophysiology|2013|203